AHL
ALXO icon

Abel Hall LLC’s ALX Oncology ALXO Stock Holding History

Abel Hall LLC’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4K Buy
12,731
+133
+1% +$238 ﹤0.01% 934
2026
Q1 		$25.3K Hold
12,598
– – 0.01% 784
2025
Q4 		$14.2K Hold
12,598
– – ﹤0.01% 709
2025
Q3 		$23.1K Sell
12,598
-2,611
-17% -$2.26K 0.01% 313
2025
Q2 		$6.31K Buy
+15,209
New +$7.68K ﹤0.01% 287
2025
Q1 		– Sell
-10,406
Closed -$17.4K – 205
2024
Q4 		$17.4K Buy
+10,406
New +$16K 0.01% 160

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Abel Hall LLC's ALXO Position: Q2 2026 in Review

Abel Hall LLC increased its ALX Oncology (ALXO) stake by 1.1% in Q2 2026, buying an estimated $238 and bringing the position to 12,731 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #934.

Abel Hall LLC first reported a position in ALXO in Q4 2024 and has held it in 6 quarters since. 94 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • Abel Hall LLC held 12,731 shares of ALX Oncology worth $26.4K as of Q2 2026.
  • Abel Hall LLC bought 133 ALX Oncology shares in Q2 2026, an estimated $238.
  • ALX Oncology made up ﹤0.01% of Abel Hall LLC's portfolio in Q2 2026, its #934 holding.
  • Abel Hall LLC first reported a position in ALX Oncology in Q4 2024 and has held it in 6 quarters since.
  • 94 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.